MEGHAN SRI KARUTURI to Paclitaxel
This is a "connection" page, showing publications MEGHAN SRI KARUTURI has written about Paclitaxel.
Connection Strength
0.085
-
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2023 Jun; 199(3):457-469.
Score: 0.034
-
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice. Cancer. 2019 09 01; 125(17):2945-2954.
Score: 0.026
-
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer. Oncologist. 2019 06; 24(6):762-771.
Score: 0.025